Clinical Translational Medicine Lead in Multiple Myeloma
Job Order: GD-723
Working with early- and/or late-stage clinical development teams, the candidate will have the opportunity to elaborate clinical biomarker plans for oncology programs from the lead selection up to submission stage.
He/she will be responsible to deliver high quality biomarker strategies for target engagement, pharmacodynamics endpoints and patient selection.
To achieve these goals, the candidate will partner with internal functions such as operational labs for biomarker assay development and clinical bioanalysis, biostatistics and precision oncology.
He/she will lead the clinical biomarker sub team with representatives from these functions, coordinating efforts for data generation, interpretation and communication to the global teams.
He/she will analyze progress, be engaged in critical thinking and be oriented towards problem-solving and risk mitigation.
PhD or MD required
3+ years in drug development or research
Experience in Multiple Myeloma/heme malignancies strongly desired
Expertise in oncology, immuno-oncology or immunology preferred
Deep understanding of the role of translational research/medicine and clinical biomarkers in drug development
Knowledge in companion diagnostic
The ability to effectively cooperate and partner with several functions within the company